Wilbury Stratton’s Life Sciences Practice works with leading pharmaceutical and biotechnology companies

Many consumers believe that pharmaceutical manufacturers have lost sight of their original vision of improving human health and are more interested in increasing profits. This is despite quality assurance processes and regulatory requirements.

Bioethics, drug testing, pharmacogenomics and drug safety lead to complex ethical discussions.

Companies engaged in biotechnology have twin issues of extensive research and development effort, and high risk of product development failures. Global patent protection and drug safety are major concerns.

Public mistrust around genetically modified seeds and plants generates criticism from consumer groups, farmers, NGOs and environmental activists in agriculture.

We help clients in the sector manage key issues of reputation management and regulatory compliance. A comprehensive strategic approach will be needed to build compliance into the way companies do business in an environment of heightened regulatory scrutiny.

Wilbury Stratton engagement

Typically at or near Board level, the senior level hires we source for clients in the industry are responsible for functions including:

• Corporate Affairs and Communication
• Ethics and Compliance
• Corporate Governance

The practice has a global reach, working on international mandates with colleagues in New York, Melbourne, Hong Kong and London.

Recent assignments include:

• Corporate Governance Director: Global Biopharmaceutical company
• Regulatory Manager Global Compliance: FTSE 100 Pharmaceutical & Healthcare company
• Global Head R&D Communications: Biotechnology Tools company

Click below to contact our specialist consultants in this practice.

lifesciences@wscl.com